Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Katz

Showing results (811-820 of 850) with videos related to

Pageof 85
Sort By:
Nature|April 6, 2017
Structural basis for selectivity and diversity in angiotensin II receptorsHaitao Zhang, Gye Won Han, Alexander Batyuk, et al.
Circulation. Cardiovascular Imaging|April 22, 2020
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR GroupAna Carolina Alba, Juan Gaztañaga, Farid Foroutan, et al.
Cancer Research|February 11, 2010
MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptorBo-Sheng Pan, Grace K Y Chan, Melissa Chenard, et al.
Journal of Medicinal Chemistry|March 4, 2025
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorDong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.
Journal of Medicinal Chemistry|April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved TolerabilityJoey L Methot, Hua Zhou, Sam D Kattar, et al.
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Journal of Cardiac Failure|February 4, 2012
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline CommitteeWilliam G Stevenson, Adrian F Hernandez, Peter E Carson, et al.
Journal of Neuroinflammation|May 4, 2020
PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human studyStal Shrestha, Min-Jeong Kim, Mark Eldridge, et al.
Circulation|September 17, 2019
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF TrialMichael E Nassif, Sheryl L Windsor, Fengming Tang, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Pageof 85

Showing results (811-820 of 850) with videos related to

Sort By:
Pageof 85
Nature|April 6, 2017
Structural basis for selectivity and diversity in angiotensin II receptorsHaitao Zhang, Gye Won Han, Alexander Batyuk, et al.
Circulation. Cardiovascular Imaging|April 22, 2020
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR GroupAna Carolina Alba, Juan Gaztañaga, Farid Foroutan, et al.
Cancer Research|February 11, 2010
MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptorBo-Sheng Pan, Grace K Y Chan, Melissa Chenard, et al.
Journal of Medicinal Chemistry|March 4, 2025
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorDong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.
Journal of Medicinal Chemistry|April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved TolerabilityJoey L Methot, Hua Zhou, Sam D Kattar, et al.
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Journal of Cardiac Failure|February 4, 2012
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline CommitteeWilliam G Stevenson, Adrian F Hernandez, Peter E Carson, et al.
Journal of Neuroinflammation|May 4, 2020
PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human studyStal Shrestha, Min-Jeong Kim, Mark Eldridge, et al.
Circulation|September 17, 2019
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF TrialMichael E Nassif, Sheryl L Windsor, Fengming Tang, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Pageof 85